Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Regeneron
Regeneron
The Next Cholesterol-Fighting Blockbuster Drug?
Motley Fool
Sun, 10/20/13 - 02:44 pm
cholesterol
hypercholesterolemia
Regeneron
Sanofi
alirocumab
Is Amarin's FDA Panel Important for Other Cardiovascular Drugmakers?
Motley Fool
Thu, 10/17/13 - 06:12 pm
FDA
Vascepa
Amarin
AstraZeneca
Regeneron
Amgen
Sanofi Cholesterol Drug Beats Merck’s Zetia in Late-Stage Study
Bloomberg
Wed, 10/16/13 - 08:03 am
Sanofi
Zetia
Merck
alirocumab
Regeneron
Top 15 Drug Launch Superstars
Fierce Pharma
Thu, 10/3/13 - 10:35 am
drug launches
Eylea
Regeneron
Bayer
Tecfidera
Biogen Idec
Kalydeco
Vertex Pharmaceuticals
Kadcyla
Roche
Genentech
Victoza
Novo Nordisk
Gilenya
Novartis
Zytiga
JNJ
Yervoy
Bristol-Myers Squibb
Stribild
Gilead Sciences Xtandi
Medivation
Astellas
Afinitor
Amgen
Prolia
Stelara
Kyprolis
Xarelto
ONYX Pharmaceuticals
Rough market day for Nektar, while Pharmacyclics and Regeneron soar
Marketwatch
Fri, 09/27/13 - 08:37 am
Nektar
Pharmacyclics
Regeneron
osteoarthritis
NKTR-181
ibrutinib
Sanofi cholesterol drug touted as potential $3 billion blockbuster
Reuters
Thu, 09/26/13 - 10:25 am
Sanofi
Regeneron
alirocumab
PCSK9 inhibitors
Who are the richest biopharma execs? Not all the usual suspects
Fierce Pharma
Tue, 09/24/13 - 11:12 am
executive pay
Regeneron
Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas
Yahoo/Wall St 24-7
Mon, 09/16/13 - 10:09 am
biotech
Th2 immune pathway
MS
multiple sclerosis
Biogen Idec
Regeneron
Sanofi
GSK
Regeneron Pharma Soars As Sanofi Mulls Doubling Stake
investors.com
Sat, 09/14/13 - 10:39 am
Regeneron
Sanofi
Biogen Tops 4 Big Biotechs For A Healthy Portfolio
Investors.com
Wed, 09/11/13 - 08:52 am
Biogen Idec
Celgene
Alexion
Regeneron
Novartis announces global licensing, research collaboration with Regenerex
Yahoo/Fly on the Wall
Fri, 09/6/13 - 08:21 am
Novartis
Regeneron
R&D
liscensing
Are Biotech M&A Premiums Already Built In? Valuations Do Matter
Seeking Alpha
Tue, 09/3/13 - 04:19 pm
biotech
M&A
ONYX Pharmaceuticals
Alexion
Biomarin
Incyte
Medivation
Pharmacyclics
Regeneron
Seattle Genetics
Regeneron's CEO Talks About His Drugs For Eye Disease, Cholesterol, And Asthma Comment Now Follow Comments
Forbes
Thu, 08/15/13 - 11:57 am
Regeneron
Pharma CEOs
Eylea
Leonard Schleifer
PCSK9 inhibitors
Between RX and A Hard Place: Biotechs Flash Warnings
Investors.com
Tue, 08/13/13 - 11:00 am
Alexion
BiogenIdec
Santarus
Regeneron
How Much To Develop A Drug? An Update
Seeking Alpha
Mon, 08/12/13 - 11:51 am
R&D
AstraZeneca
Bayer
Eli Lilly
Novartis
Pfizer
Regeneron
Roche
Shire
Takeda
Regeneron: Q2 Results And Eylea Data Support The Long-Term Thesis
Seeking Alpha
Sat, 08/10/13 - 12:37 pm
Regeneron
earnings
Regeneron: Q2 Results And Eylea Data Support The Long-Term Thesis
Seeking Alpha
Fri, 08/9/13 - 04:57 pm
earnings
Regeneron
Eylea
Amgen
Novartis
Pfizer
Sanofi
Should You Keep an Eye on These Eye Treatment Biotechs?
Motley Fool
Fri, 08/9/13 - 10:30 am
wet age-related macular degeneration
diabetic macular edema
Lucentis
Novartis
Roche
Eylea
Regeneron
Optina
Ampio Pharmaceuticals
Is There Pipeline Potential in These 3 Biotech Stocks?
Motley Fool
Thu, 08/8/13 - 09:02 am
Regeneron
REGN-727
dupilumab
Abexinostat
Pharmacyclics
AVI-7288
Sarepta Therapeutics
Regeneron Posts Rare Sales Miss But Counters With Early FDA Filing
TheStreet.com
Tue, 08/6/13 - 11:00 am
Regeneron
FDA
earnings
Eylea
DME
Pages
« first
‹ previous
…
35
36
37
38
39
40
41
42
43
…
next ›
last »